Molecular Biosystems Weighing Options After Palatin Exits Merger Talks
This article was originally published in The Gray Sheet
Executive Summary
Molecular Biosystems, Inc. is exploring alternatives to a previously planned merger with Palatin Technologies and expects to reach a decision by mid-April, following Palatin's March 14 decision not to proceed with the deal. Options under consideration include remaining independent or looking for another merger partner, MBI says.